Pharmacokinetics of an indomethacin pro-drug: apyramide after intravenous administration in dog.
The pharmacokinetics of apyramide, an ester of indomethacin and acetaminophen (paracetamol), were determined after intravenous administration to nine beagle dogs. Indomethacin and its pro-drug, apyramide, were extracted from acetonitrile-precipitated plasma by a solvent-demixing procedure and the concentration of these two drugs was measured by a reversed-phase liquid chromatographic assay. The kinetic evolution with time of plasma levels of apyramide and of indomethacin resulting from enzymatic hydrolysis was compared with values obtained for indomethacin injected in equimolar dose. Plasma levels of apyramide quickly decreased and the mean (+/- SD) half life was 0.15 +/- 0.08 h. For metabolic indomethacin, the mean (+/- SD) area under curve was 12.36 +/- 4.80 mg.h/l and the mean (+/- SD) half life of terminal phase was 16.71 +/- 9.46 h. After administration of indomethacin, these values were 17.60 +/- 4.12 mg.h/l and 7.89 +/- 2.20 h, respectively.
Cociglio
M
M
Laboratoire de Pharmacodynamie, Faculté de Pharmacie, Montpellier, France.
Bres
J
J
Sauvaire
D
D
Alric
R
R
Richard
M
M
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D005260:Female; D006207:Half-Life; D007210:Indoleacetic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007213:Indomethacin / Q000493:pharmacokinetics*; D007275:Injections, Intravenous; D011355:Prodrugs / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013056:Spectrophotometry, Ultraviolet
D007210:Indoleacetic Acids; D011355:Prodrugs; C054255:apyramide; D007213:Indomethacin